Submucosal tumor appearance is a useful endoscopic predictor of early primary-site recurrence after definitive chemoradiotherapy for esophageal squamous cell carcinoma

Diseases of the Esophagus

Volumn 24, Issue 4, 2011, Pages 274-278

  Tu, C H ^a   Muto, M ^b   Horimatsu, T ^b   Taku, K ^c   Yano, T ^d   Minashi, K ^d   Onozawa, M ^d   Nihei, K ^d   Ishikura, S ^d   Ohtsu, A ^d   Yoshida, S ^d  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b KYOTO UNIVERSITY   (Japan)

^c SHIZUOKA CANCER CENTER   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Chemoradiotherapy; Esophageal cancer; Recurrence; Surveillance

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CHEMORADIOTHERAPY; EARLY DIAGNOSIS; EROSION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS STRICTURE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; STOMACH TUMOR;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; EARLY DETECTION OF CANCER; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 79956221825     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2010.01141.x     Document Type: Article

References (26)

1. Cooper J S, Guo M D, Herskovic A etal. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA 1999; 81: 1623-7.
2. Suntharalingam M, Moughan J, Coia L R etal. The national practice for patients receiving radiation therapy for carcinoma of the esophagus: results of the 1996-1999 Patterns of Care Study. Int J Radiat Oncol Biol Phys 2003; 56: 981-7.
3. Herskovic A, Martz K, Al-Sarraf M etal. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
4. Kavanagh B, Anscher M, Leopold K etal. Patterns of failure following combined modality therapy for esophageal cancer, 1984-90. Int J Radiat Oncol Biol Phys 1992; 24: 633-42.
5. Gill P G, Denham J W, Jamieson G G etal. Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery. J Clin Oncol 1992; 10: 1037-43.
6. Meunier B, Raoul J, Le Prise E etal. Salvage esophagectomy after unsuccessful curative chemoradiotherapy for squamous cell cancer of the esophagus. Dig Surg 1998; 15: 224-6.
7. Swisher S G, Wynn P, Putnam J B etal. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 2002; 123: 175-83.
8. Nakamura T, Hayashi K, Ota M etal. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg 2004; 188: 261-6.
9. Yano T, Muto M, Minashi K etal. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy 2008; 40: 717-21.
10. Yano T, Muto M, Minashi K etal. Photodynamic therapy as salvage treatment for local failures after definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc 2005; 62: 31-6.
11. Mandard A M, Dalibard F, Mandard J C etal. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994; 73: 2680-6.
12. Brucher B L, Becker K, Lordick F etal. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas. Cancer 2006; 106: 2119-27.
13. Ajani J, Bekaii-Saab T, D'Amico T A etal. Esophageal cancer clinical practice guidelines. J Natl Compr Canc Netw 2006; 4: 328-47.
14. Sobin L, Wittekind C. International Union Against Cancer (UICC). TNM Classification of Malignant Tumors, 5th edn. New York: Wiley-Liss, 1997.
15. Mori M, Adachi Y, Matsushima T etal. Lugol staining pattern and histology of esophageal lesions. Am J Gastroenterol 1993; 88: 701-5.
16. Silverstein F E, Tytgat G N. Gastrointestinal Endoscopy, 3rd edn. Edinburgh, UK: Mosby, 2002.
17. Darnton S J, Allen S M, Edwards C W etal. Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy. J Clin Pathol 1993; 46: 51-5.
18. Junker K, Thomas M, Schulmann K etal. Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment. J Cancer Res Clin Oncol 1997; 123: 469-77.
19. Zuccaro G Jr, Rice T W, Goldblum J etal. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol 1999; 94: 906-12.
20. Beseth B D, Bedford R, Isacoff W H etal. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Am Surg 2000; 66: 827-31.
21. Ott K, Weber W, Siewert J R. The importance of PET in the diagnosis and response evaluation of esophageal cancer. Dis Esophagus 2006; 19: 433-42.
22. Flamen P, Lerut A, Van Cutsem E etal. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer. J Thorac Cardiovasc Surg 2000; 120: 1085-92.
23. Kato H, Miyazaki T, Nakajima M etal. Value of positron emission tomography in the diagnosis of recurrent esophageal carcinoma. Br J Surg 2004; 91: 1004-9.
24. Nakamura R, Obara T, Katsuragawa S etal. Failure in presumption of residual disease by quantification of FDG uptake in esophageal squamous cell carcinoma immediately after radiotherapy. Radiat Med 2002; 4: 181-6.
25. Wieder H A, Brucher B L, Zimermann F etal. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 2004; 22: 900-8.
26. Dittler H J, Fink U, Siewert G R. Response to chemotherapy in esophageal cancer. Endoscopy 1994; 26: 769-71.